Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InfuSystems Holdings, Inc. (INFU : AMEX)

• Company Description    InfuSystem is a rapidly growing healthcare services company that provides state-of-the-art electronic continuous ambulatory infusion pumps, supplies and support to oncology practices and clinics throughout the United States. More than 60% of oncologists across all 50 states turn to InfuSystem as their single, full-service source for cost-effective infusion pump management. Number of Employees: 473

• Price / Volume Information    Yesterday's Closing Price: $12.24 Daily Weekly Monthly 20 Day Moving Average: 101,362 shares Shares Outstanding: 20.18 (millions) Market Capitalization: $247.02 (millions) Beta: 1.50 52 Week High: $12.97 52 Week Low: $7.29 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.00% -1.51% 12 Week 33.92% 28.93% Year To Date 36.46% 21.02%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3851 West Hamlin Road - Rochester Hills,MI 48309 USA ph: 248-291-1210 fax: 800-455-4338 None http://www.infusystem.com

• General Corporate Information    Officers Carrie Lachance - Chief Executive Officer and Director Scott Shuda - Chairman Barry Steele - Chief Financial Officer Kenneth Eichenbaum - Director Paul Gendron - Director Peer Information InfuSystems Holdings, Inc. (BJCT) InfuSystems Holdings, Inc. (CADMQ) InfuSystems Holdings, Inc. (APNO) InfuSystems Holdings, Inc. (UPDC) InfuSystems Holdings, Inc. (IMTIQ) InfuSystems Holdings, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 45685K102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/03/26 Share - Related Items Shares Outstanding: 20.18 Most Recent Split Date: (:1) Beta: 1.50 Market Capitalization: $247.02 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 29.85 PEG Ratio: - Price Ratios Price/Book: 4.18 Price/Cash Flow: 12.44 Price / Sales: 1.72 EPS Growth vs. Year Ago Period: 25.00% vs. Previous Quarter: 200.00% Sales Growth vs. Year Ago Period: 2.59% vs. Previous Quarter: 9.65% ROE 06/30/26 - 14.81 03/31/26 - 14.00 12/31/25 - 11.91 ROA 06/30/26 - 8.63 03/31/26 - 7.93 12/31/25 - 6.55 Current Ratio 06/30/26 - 2.50 03/31/26 - 2.14 12/31/25 - 1.80 Quick Ratio 06/30/26 - 2.14 03/31/26 - 1.80 12/31/25 - 1.53 Operating Margin 06/30/26 - 5.96 03/31/26 - 5.56 12/31/25 - 4.62 Net Margin 06/30/26 - 5.96 03/31/26 - 5.56 12/31/25 - 4.62 Pre-Tax Margin 06/30/26 - 8.52 03/31/26 - 8.28 12/31/25 - 7.41 Book Value 06/30/26 - 2.93 03/31/26 - 2.91 12/31/25 - 2.82 Inventory Turnover 06/30/26 - 10.92 03/31/26 - 10.96 12/31/25 - 11.10 Debt-to-Equity 06/30/26 - 0.35 03/31/26 - 0.33 12/31/25 - 0.34 Debt-to-Capital 06/30/26 - 25.67 03/31/26 - 25.06 12/31/25 - 25.50

Powered by Zacks Investment Research ©